MCRB Chart
- 52-Week Range: $3.34 - $24.36
- Market Capitalization: $318.38M
- Short Percentage: 0%
- Target Price: $16.50
- Shares Outstanding: 92.23M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
MCRB released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- Seres Therapeutics, Inc. (MCRB) CEO Eric Shaff on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha | March 1st
- Seres Therapeutics to Present at Chardan Metagenomics and Microbiome Medicines SummitBusiness Wire | February 22nd
- Seres Therapeutics Appoints Paula Cloghessy as Executive Vice President, Chief People OfficerBusiness Wire | February 8th
Company Info
Website: https://www.serestherapeutics.com
Address: 200 Sidney Street, Cambridge, MA, United States, 02139
Sector: Healthcare
Industry: Biotechnology
Full time employees: 333
Address: 200 Sidney Street, Cambridge, MA, United States, 02139
Sector: Healthcare
Industry: Biotechnology
Full time employees: 333
$MCRB MAY RIP TOMORROW
$MCRB buy and HODL
$MCRB There is nothing wrong with a decent pullback
$MCRB buy bitches
$MCRB hold
$MCRB lock and load
$MCRB still holding and buying.